144 related articles for article (PubMed ID: 30280953)
21. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
[TBL] [Abstract][Full Text] [Related]
22. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
23. Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats.
Chung CY; Yang JT; Kuo YC
Biomaterials; 2013 Dec; 34(37):9717-27. PubMed ID: 24034503
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.
Ebrahimi Shahmabadi H; Movahedi F; Koohi Moftakhari Esfahani M; Alavi SE; Eslamifar A; Mohammadi Anaraki G; Akbarzadeh A
Tumour Biol; 2014 May; 35(5):4799-806. PubMed ID: 24443270
[TBL] [Abstract][Full Text] [Related]
25. [The research on IR and TEM of polybutylcyanoacrylate nanoparticles].
Li X; Zhu YF; Zhao MJ
Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Apr; 23(2):266-9. PubMed ID: 12961866
[TBL] [Abstract][Full Text] [Related]
26. Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo.
Kolter M; Ott M; Hauer C; Reimold I; Fricker G
J Control Release; 2015 Jan; 197():165-79. PubMed ID: 25445700
[TBL] [Abstract][Full Text] [Related]
27. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in drug and nutrient transport across the blood-retinal barrier.
Kubo Y; Akanuma SI; Hosoya KI
Expert Opin Drug Metab Toxicol; 2018 May; 14(5):513-531. PubMed ID: 29719158
[TBL] [Abstract][Full Text] [Related]
29. Live
Tawfik M; Hadlak S; Götze C; Sokolov M; Kulikov P; Kuskov A; Shtilman M; Sabel BA; Henrich-Noack P
J Biomed Nanotechnol; 2021 May; 17(5):846-858. PubMed ID: 34082871
[TBL] [Abstract][Full Text] [Related]
30. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
31. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
[TBL] [Abstract][Full Text] [Related]
32. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
[TBL] [Abstract][Full Text] [Related]
33. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
Girotra P; Singh SK
Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
[TBL] [Abstract][Full Text] [Related]
34. Transcellular Model for Neutral and Charged Nanoparticles Across an In Vitro Blood-Brain Barrier.
Zhang L; Fan J; Li G; Yin Z; Fu BM
Cardiovasc Eng Technol; 2020 Dec; 11(6):607-620. PubMed ID: 33113565
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle delivery to the brain--By focused ultrasound and self-assembled nanoparticle-stabilized microbubbles.
Åslund AKO; Berg S; Hak S; Mørch Ý; Torp SH; Sandvig A; Widerøe M; Hansen R; de Lange Davies C
J Control Release; 2015 Dec; 220(Pt A):287-294. PubMed ID: 26518721
[TBL] [Abstract][Full Text] [Related]
36. Indinavir-Loaded Nanostructured Lipid Carriers to Brain Drug Delivery: Optimization, Characterization and Neuropharmacokinetic Evaluation.
Nasiri M; Azadi A; Zanjani MRS; Hamidi M
Curr Drug Deliv; 2019; 16(4):341-354. PubMed ID: 30674257
[TBL] [Abstract][Full Text] [Related]
37. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Kuo YC; Kuo CY
Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
[TBL] [Abstract][Full Text] [Related]
38. In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish.
Watanabe K; Nishimura Y; Nomoto T; Umemoto N; Zhang Z; Zhang B; Kuroyanagi J; Shimada Y; Shintou T; Okano M; Miyazaki T; Imamura T; Tanaka T
BMC Neurosci; 2012 Aug; 13():101. PubMed ID: 22894547
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy.
Weyermann J; Lochmann D; Georgens C; Rais I; Kreuter J; Karas M; Wolkenhauer M; Zimmer A
Eur J Pharm Biopharm; 2004 Jul; 58(1):25-35. PubMed ID: 15207534
[TBL] [Abstract][Full Text] [Related]
40. Toxicity of polymeric nanoparticles in vivo and in vitro.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
J Nanopart Res; 2014 Jun; 16(6):. PubMed ID: 26420981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
